[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-363629-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-363629-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dgat1-inhibition-induces-ferroptosis-and-enhances-cancer-immunotherapy-efficacy","DGAT1 Inhibition Induces Ferroptosis and Enhances Cancer Immunotherapy Efficacy","","DGAT1 is a metabolic enzyme involved in triglyceride synthesis and lipid droplet formation, helping cancer cells buffer lipid-mediated stress while supporting survival and resistance. The study shows that inhibiting DGAT1 drives a ferroptosis-like phenotype characterized by reduced lipid droplets, increased lipid peroxidation, mitochondrial dysfunction, reactive oxygen species production, glutathione peroxidase 4 depletion, and ferroptosis. Across human cohorts, low DGAT1 correlates with better prognosis and ferroptosis gene signatures, while in mice DGAT1 knockout or pharmacologic inhibition enhances immune checkpoint blockade efficacy by increasing cytotoxic T-cell infiltration.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dgat1-inhibition-induces-ferroptosis-and-enhances-cancer-immunotherapy-efficacy/363629/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dgat1-inhibition-induces-ferroptosis-and-enhances-cancer-immunotherapy-efficacy/363629.png","ImageObject",300,407,{"name":42,"@type":43},"Kurz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does DGAT1 do that is relevant to cancer therapy?","Question",{"text":63,"@type":64},"DGAT1 catalyzes the final step of triglyceride synthesis, promoting lipid droplet formation that helps cells store energy and protect against cytotoxic stress from free fatty acids and reactive oxygen species.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does DGAT1 inhibition trigger ferroptosis-like cell death?",{"text":68,"@type":64},"DGAT1 inhibition reduces lipid droplet accumulation, leading to elevated lipid peroxidation, mitochondrial dysfunction, and increased reactive oxygen species. These changes culminate in GPX4 depletion and ferroptosis.",{"name":70,"@type":61,"acceptedAnswer":71},"How does DGAT1 inhibition improve immune checkpoint blockade outcomes?",{"text":72,"@type":64},"In murine models, genetic knockout or pharmacologic inhibition of DGAT1 enhances immune checkpoint blockade efficacy by promoting increased infiltration of cytotoxic T lymphocytes into tumors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},363629,1790211997,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478945635,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","DGAT1 Inhibition Induces Ferroptosis and Enhances Cancer Immunotherapy Efficacy  \nDong Pan1,2, Meng Jiao2, Yanyan Zhu3, Mengjie Hu2, Fang Li2, Jinming Yu1, and Chuan-Yuan Li2,3,4  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | Ferroptosis, a form of regulated cell death driven by lipid peroxidation, has emerged as a promising mechanism in cancer therapy. However, the lack of clinically viable ferroptosis inducers has precluded its therapeutic evaluation in patients. In this study, we demonstrated that inhibition of diacylglycerol O-acyltransferase 1 (DGAT1) induces a ferroptosis-like phenotype in cancer cells and enhances the efficacy of immune checkpoint blockade (ICB) therapy. In human cancer cohorts, low DGAT1 expression correlated with improved prognosis and elevated ferroptosis-associated gene signatures. In murine models, both genetic knockout and pharmacologic inhibition of DGAT1 enhanced ICB therapy efficacy by promoting increased infiltration of cytotoxic T lymphocytes. Mechanistically, DGAT1 inhibition reduced lipid droplet accumulation, triggering elevated lipid peroxidation, mitochondrial dysfunction, and reactive oxygen species production. These events culminated in glutathione peroxidase 4 depletion and ferroptosis. Given the availability of clinical-stage DGAT1 inhibitors, these findings provide a strong rationale for repurposing these agents as ferroptosis inducers to improve responses to cancer immunotherapy.\u003Cbr>Significance: DGAT1 inhibition promotes ferroptosis by reducing lipid droplet accumulation, increasing lipid peroxidation, and inducing mitochondrial dysfunction, ultimately enhancing\u003Cbr>􀀶 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | sensitivity to immune checkpoint blockade and offering a promising strategy for improving cancer treatment.\u003Cbr>\u003Cbr>Normal DGAT1 DGAT1 deficiency\u003Cbr>Mitochondrion\u003Cbr>Tricarboxylic acid cycle\u003Cbr>Acylcarnitines\u003Cbr>ATP\u003Cbr>Tumor growth\u003Cbr>Fatty acids (FA)\u003Cbr>Acyl-coA\u003Cbr>FA/acyl-coA\u003Cbr>TAG\u003Cbr>DAG\u003Cbr>DGAT1\u003Cbr>LDs\u003Cbr>Cold tumor\u003Cbr>(no response to ICB)\u003Cbr>Mitochondrion\u003Cbr>Δψm\u003Cbr>Acylcarnitines\u003Cbr>ROS\u003Cbr>FAs\u003Cbr>DAG Acyl-coA\u003Cbr>FA/acyl-coADGAT1 TAG\u003Cbr>Reduced LDs\u003Cbr>GSH depletion\u003Cbr>GPX4 degradation\u003Cbr>Lipid peroxidation\u003Cbr>Ferroptosis\u003Cbr>Activated immune response\u003Cbr>Hot tumor (increased response to ICB)\u003Cbr>Created in BioRender. Wang, Q. (2026) [https://BioRender.com/142494k](https://BioRender.com/142494k) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nDiacylglycerol O-acyltransferase 1 (DGAT1) catalyzes the final step of triglyceride (TG) synthesis by transferring an acyl group from acyl-CoA to diacylglycerol (DAG) . This process facilitates the formation of lipid droplets (LD), intracellular organelles  \n1Department of Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. 2Departme","cbCaiordZDVWzxDB","https://ap.wps.com/l/cbCaiordZDVWzxDB","pdf",5683137,14,"English","# Introduction\n# Mechanistic basis of DGAT1 inhibition and ferroptosis\n# DGAT1 expression and prognostic relevance in human cohorts\n# DGAT1 inhibition and effects on immune checkpoint blockade in murine models\n# Therapeutic implications and rationale for drug repurposing","[{\"question\":\"What does DGAT1 do that is relevant to cancer therapy?\",\"answer\":\"DGAT1 catalyzes the final step of triglyceride synthesis, promoting lipid droplet formation that helps cells store energy and protect against cytotoxic stress from free fatty acids and reactive oxygen species.\"},{\"question\":\"How does DGAT1 inhibition trigger ferroptosis-like cell death?\",\"answer\":\"DGAT1 inhibition reduces lipid droplet accumulation, leading to elevated lipid peroxidation, mitochondrial dysfunction, and increased reactive oxygen species. These changes culminate in GPX4 depletion and ferroptosis.\"},{\"question\":\"How does DGAT1 inhibition improve immune checkpoint blockade outcomes?\",\"answer\":\"In murine models, genetic knockout or pharmacologic inhibition of DGAT1 enhances immune checkpoint blockade efficacy by promoting increased infiltration of cytotoxic T lymphocytes into tumors.\"}]","DGAT1 Inhibition Induces Ferroptosis and Enhances Cancer Immunotherapy Efficacy | PDF",1790152252,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e6d8c59637ed9e9697e097aae0c5f01.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20fb4397e3a4ee796c74d20353ee2e8f.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1e0f3aead74f32af583ac0ae1b364c7.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/903ca0169e122eaa492f1b026a6b3123.webp",980,1311]